Dsp Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option
NAV (R) % (D) %
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular
Direct
Nifty Pharma TRI 12.8% 26.24% 14.52% 14.92% 7.65%
SIP (XIRR) Regular
Direct
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.08 0.59 0.96 0.33% -0.47
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
14.57% -17.66% -13.27% 0.8 9.99%
Fund AUM As on: 30/12/2025 3140 Cr

No data available

NAV Date:

no data

Review Date:

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 14.57
15.51
14.34 | 16.43 2 | 8 Very Good
Semi Deviation 9.99
10.99
9.99 | 11.68 1 | 8 Very Good
Max Drawdown % -13.27
-14.76
-16.36 | -12.33 2 | 8 Very Good
VaR 1 Y % -17.66
-18.18
-21.68 | -15.67 5 | 8 Average
Average Drawdown % -3.66
-5.42
-6.79 | -3.66 1 | 8 Very Good
Sharpe Ratio 1.08
1.19
1.08 | 1.37 8 | 8 Poor
Sterling Ratio 0.96
1.02
0.92 | 1.18 7 | 8 Poor
Sortino Ratio 0.59
0.63
0.56 | 0.72 7 | 8 Poor
Jensen Alpha % 0.33
1.56
-0.45 | 4.64 6 | 8 Average
Treynor Ratio -0.47
-0.42
-0.47 | -0.39 8 | 8 Poor
Modigliani Square Measure % 24.56
26.49
24.56 | 29.65 8 | 8 Poor
Alpha % -2.78
-1.30
-2.78 | 1.82 8 | 8 Poor
Return data last Updated On :
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Feb. 27, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
Standard Deviation 14.57 15.51 14.34 | 16.43 2 | 8 Very Good
Semi Deviation 9.99 10.99 9.99 | 11.68 1 | 8 Very Good
Max Drawdown % -13.27 -14.76 -16.36 | -12.33 2 | 8 Very Good
VaR 1 Y % -17.66 -18.18 -21.68 | -15.67 5 | 8 Average
Average Drawdown % -3.66 -5.42 -6.79 | -3.66 1 | 8 Very Good
Sharpe Ratio 1.08 1.19 1.08 | 1.37 8 | 8 Poor
Sterling Ratio 0.96 1.02 0.92 | 1.18 7 | 8 Poor
Sortino Ratio 0.59 0.63 0.56 | 0.72 7 | 8 Poor
Jensen Alpha % 0.33 1.56 -0.45 | 4.64 6 | 8 Average
Treynor Ratio -0.47 -0.42 -0.47 | -0.39 8 | 8 Poor
Modigliani Square Measure % 24.56 26.49 24.56 | 29.65 8 | 8 Poor
Alpha % -2.78 -1.30 -2.78 | 1.82 8 | 8 Poor
Return data last Updated On :
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Feb. 27, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Dsp Healthcare Fund NAV Regular Growth Dsp Healthcare Fund NAV Direct Growth
12-03-2026 36.919 41.099
11-03-2026 37.183 41.392
10-03-2026 37.184 41.392
09-03-2026 37.081 41.276
06-03-2026 37.038 41.223
05-03-2026 37.398 41.623
04-03-2026 37.119 41.311
02-03-2026 37.814 42.081
27-02-2026 38.105 42.4
26-02-2026 38.221 42.528
25-02-2026 37.888 42.156
24-02-2026 37.349 41.554
23-02-2026 37.351 41.556
20-02-2026 37.075 41.244
19-02-2026 37.236 41.421
18-02-2026 37.613 41.84
17-02-2026 37.272 41.458
13-02-2026 37.03 41.184

Fund Launch Date: 12/Nov/2018
Fund Category: Pharma Fund
Investment Objective: The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there can be no assurance that the investment objective of the scheme will be realized.
Fund Description: An open ended equity scheme investing in healthcare and pharmaceutical sector
Fund Benchmark: S&P BSE HEALTHCARE (Total Return Index)
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.